Healthcare -
Biotechnology - NASDAQ - CH
$ 3.84
-5.04 %
$ 142 M
Market Cap
-1.94
P/E
MOLN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities MOLN - Molecular Partners AG
40.5 M
LAST VALUE
54.93%
2 YEAR CAGR
32.22%
5 YEAR CAGR
70.38%
10 YEAR CAGR